Arnaud Demange
ORCID：0009-0001-3363-6051
发表论文 35 篇 · 总被引 140 次 · h-index 5
代表论文
- Final overall survival in the phase 3 NETTER-1 study of lutetium-177-DOTATATE in patients with midgut neuroendocrine tumors. (2021 · Journal of Clinical Oncology · 被引 76)
- Dosimetry of [ 177 Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial (2025 · Journal of Nuclear Medicine · 被引 29)
- 671P LuMIERE: A phase I/II study evaluating safety, dosimetry, and preliminary activity of [177Lu]Lu-FAP-2286 in patients with advanced solid tumors (2024 · Annals of Oncology · 被引 17)
- Preliminary diagnostic performance of [68Ga ]-NeoBOMB1 in patients with gastrin-releasing peptide receptor-positive breast, prostate, colorectal or lung tumors (NeoFIND) (2020 · Journal of Nuclear Medicine · 被引 7)
- Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial (2026 · Clinical Cancer Research · 被引 6)
- 1102P The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses (2021 · Annals of Oncology · 被引 2)